Individual Genome Sequencing Will Become Part of Any Treatment

Individual genome sequencing will become part of any treatment
New cancer drugs and therapies, for example, have long been developed in large, lengthy, expensive clinical trials where success is measured by improvements that last only a few weeks. What happens to drugs and treatments that don't have a … Before … Read more on La Jolla Light

Aixplorer® Expert Edition to be Unveiled at RSNA 2013
Dr. James Trotter, MD of Baylor University Medical Center in Dallas, Texas said “ShearWave Elastography is done identically to ultrasonography so it's a very comfortable and simple exam for the patient and it takes only 30 -90 seconds to perform. It … Read more on Business Wire (press release)

Study of human blood fluke parasites identifies drug resistance mutations
21, 2013 — An international group of scientists led by Tim Anderson Ph.D., at the Texas Biomedical Research Institute and Philip LoVerde Ph.D., at the University of Texas Health Science Center at San Antonio has identified the mutations that result in … Read more on Science Daily (press release)

SABCS 2013 Preview: Breast Cancer Diagnosis and Treatment
The symposium co-directors, Peter Ravdin, MD, PhD, University of Texas Health Science Center, San Antonio; Carlos L. Arteaga, MD, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; and C. Kent Osborne, MD, Baylor College of Medicine, Houston … Read more on OncLive